Point72 Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-837,426
Closed -$115M 1581
2024
Q1
$115M Sell
837,426
-554,544
-40% -$76.5M 0.28% 67
2023
Q4
$183M Sell
1,391,970
-1,186,158
-46% -$156M 0.44% 23
2023
Q3
$290M Buy
2,578,128
+2,466,770
+2,215% +$278M 0.85% 7
2023
Q2
$10.5M Buy
+111,358
New +$10.5M 0.03% 501
2022
Q3
Sell
-665,300
Closed -$64.9M 1261
2022
Q2
$64.9M Buy
665,300
+87,402
+15% +$8.52M 0.27% 83
2022
Q1
$54.2M Buy
577,898
+50,124
+9% +$4.7M 0.22% 125
2021
Q4
$45M Buy
527,774
+378,826
+254% +$32.3M 0.18% 151
2021
Q3
$14.3M Buy
+148,948
New +$14.3M 0.06% 378
2021
Q1
Sell
-22,679
Closed -$2.17M 1051
2020
Q4
$2.17M Buy
+22,679
New +$2.17M 0.01% 677
2020
Q2
Sell
-18,124
Closed -$1.57M 909
2020
Q1
$1.57M Sell
18,124
-41,879
-70% -$3.63M 0.01% 503
2019
Q4
$6.45M Buy
60,003
+30,459
+103% +$3.27M 0.03% 429
2019
Q3
$2.66M Sell
29,544
-1,095,140
-97% -$98.7M 0.02% 508
2019
Q2
$95M Buy
1,124,684
+735,992
+189% +$62.1M 0.5% 41
2019
Q1
$34.2M Buy
+388,692
New +$34.2M 0.16% 138
2018
Q4
Sell
-65,000
Closed -$7.99M 1001
2018
Q3
$7.99M Sell
65,000
-830,900
-93% -$102M 0.03% 390
2018
Q2
$88M Buy
895,900
+820,900
+1,095% +$80.6M 0.35% 53
2018
Q1
$6.22M Buy
+75,000
New +$6.22M 0.03% 425
2017
Q4
Sell
-276,322
Closed -$16.9M 868
2017
Q3
$16.9M Sell
276,322
-310,678
-53% -$19M 0.08% 250
2017
Q2
$27M Buy
587,000
+487,000
+487% +$22.4M 0.15% 159
2017
Q1
$4.33M Buy
+100,000
New +$4.33M 0.02% 509
2015
Q3
Sell
-37,700
Closed -$1.8M 799
2015
Q2
$1.8M Sell
37,700
-195,500
-84% -$9.34M 0.01% 535
2015
Q1
$9.26M Buy
+233,200
New +$9.26M 0.06% 318